Pangea Natural Foods Acquires Amino Innovations to Revolutionize Peptide Delivery
Vancouver, BC -- March 25, 2025 -- NewsGenie -- Pangea Natural Foods Inc. (CSE: PNGA) (OTCQB: PNGAF) has finalized a share purchase agreement to acquire Amino Innovations Corp. Amino is focused on developing peptide therapies with innovative delivery systems, aiming to become the world's first needleless peptide company. Their product line targets stress management, gut health, longevity, and more.
Under the agreement, Pangea will acquire 100% of Amino's shares in exchange for 12,000,000 Pangea common shares at $0.20 each. Amino's management will continue to oversee operations.
The Consideration Shares will be issued under prospectus exemptions pursuant to National Instrument 45-106 and will be subject to contractual restrictions on transfer. The Consideration Shares will be released in accordance with the following schedule:
a) 20% of the Consideration Shares on the date that is 12 months following closing of the acquisition
b) 20% of the Consideration Shares on the date that is 18 months following the Closing Date
c) 20% of the Consideration Shares on the date that is 24 months following the Closing Date
d) 20% of the Consideration Shares on the date that is 30 months following the Closing Date
e) 20% of the Consideration Shares on the date that is 36 months following the Closing Date.
An additional 20% of Consideration Shares will be released if Amino reaches $2 million in revenue within 12 months of closing. A 15 percent finder's fee, payable in Pangea shares, will be issued to arm’s length parties.
"We focused on high-growth options that promote health and longevity – Amino is developing exactly that," stated Pangea CEO Pratap Sandhu. Samples will be shared with consumers before product launches later in the year.
The acquisition is subject to regulatory and third-party approvals.
Pangea Natural Foods Inc. manufactures and distributes plant-based food and health products across North America.